Results 201 to 210 of about 394,456 (275)

Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study. [PDF]

Neurol Open Access
St Sauver JL, Hall SA, Jacobson RM, Keegan BM, Fan C, McPhee RA, Buck PO, Diaz-Decaro J.   +7 more
europepmc   +1 more source

L’Odio nella condizione moderna o iper-moderna

, 2022
openaire   +1 more source

Cross-national patterns of COVID-19 vaccination coverage by vaccine type. [PDF]

PLOS Glob Public Health
Al-Zyoud W, Erekat D, Abudayah M.
europepmc   +1 more source

A Response to: Letter to the Editor Regarding “Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults”

Infectious Diseases and Therapy
Mihaela Georgieva, Tianyu Sun, Ekkehard Beck   +2 more
doaj   +1 more source

[The survival of Antiquity on the covers and int he drug ads of Eu Sei Tudo magazine, 1917-1958]. [PDF]

Hist Cienc Saude Manguinhos
Maia ACN, Liborio DS.
europepmc   +1 more source

Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345. [PDF]

Clin Infect Dis
Mayer EF, Falsey AR, Wolfe CR, Herc E, Burns F, Kabbani D, Kumar D, Mannan A, She F, Lan L, McGrath S, Kapoor A, Priddy F.   +12 more
europepmc   +1 more source

A Response to: A Letter to the Editor Regarding ‘Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework’

Infectious Diseases and Therapy
Ekkehard Beck, Mary T. Bausch-Jurken, Nicolas Van de Velde, Xuan Wang, Mia Malmenäs   +4 more
doaj   +1 more source

Immunomodulatory LNP-mRNA therapeutics: The next phase of precision immuno-engineering. [PDF]

Mol Ther Nucleic Acids
Patel K, Egelston C, Scott T.
europepmc   +1 more source

Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial. [PDF]

Hum Vaccin Immunother
Comstock E, Fogarty C, Caso J, Vu J, Sinha A, Cao X, Chen H, Rushton L, Ma C, Priddy F.   +9 more
europepmc   +1 more source

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in <i>BRAF</i> V600-Mutant Advanced Melanoma. [PDF]

J Clin Oncol
Ribas A, Robert C, Schadendorf D, Long GV, Tawbi H, Flaherty K, Ascierto PA, Nathan P, Rutkowski P, Leonov OV, Lorigan P, Prey S, Saponara M, Arance A, Gaudy-Marqueste C, Stroyakovskiy D, Lebbe C, Maio M, Del Vecchio M, Boghikian PS, Gutzmer R, Depenni R, Miskic M, Russo M, Dummer R.   +24 more
europepmc   +1 more source